Forbes
This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time

NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.
F
Source
Forbes
Read full article at Forbes
Opens original article in a new tab
Advertisement